Mepidental (Mepivacaine Hydrochloride)

Mepivacaine works by reversibly blocking voltage‑gated sodium channels on nerve membranes. This prevents the rapid influx of sodium ions needed for depolarisation, halting the transmission of nerve impulses and resulting in temporary loss of sensation in the injected region.

The dose of Mepidental is determined by the prescribing clinician based on the specific procedure, patient weight, and clinical judgment. Only a qualified healthcare professional should calculate and administer the appropriate amount.

The safety of mepivacaine in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order Mepidental, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mepivacaine has a rapid onset and intermediate duration, similar to lidocaine but with slightly less vasodilatory effect. Compared with bupivacaine, it provides a shorter duration of action, which can be advantageous for brief procedures where prolonged numbness is not desired.

Mepidental should be stored at room temperature, below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture and extreme temperatures. Do not freeze; discard any product that appears discoloured or contains particles.

Mepidental is administered by infiltration, peripheral nerve block or other local injection techniques performed by a qualified healthcare professional. The solution is injected directly into the target tissue or nerve area using aseptic technique and appropriate needle size.

Serious risks include cardiovascular collapse, severe allergic reactions (anaphylaxis), central nervous system toxicity such as seizures, and rare events like methemoglobinemia. Prompt recognition and supportive management are essential if any of these events occur.

Mepidental should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, severe cardiac conduction disorders, or those taking Class I anti‑arrhythmic drugs. It should also be used with caution in patients with significant liver disease or uncontrolled epilepsy.